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1. Introduction 
Aortic stenosis (AS) is the most frequent valvular heart disease in west developed and 
developing countries, with prevalence between 0.02% in adults under 44 years and 3-9% in 
elderly over 80 years. Patients with this disease may remain asymptomatic for years, 
particularly in elderly with naturally limited exercise. If the patients remain untreated after 
they become symptomatic, the mortality at 10 years follow-up is 80-90%. Based on the 
etiology, mainly are three types of AS: 1) Calcific AS, which is most frequent type in adults 
of advanced age (2–7% of the population), 2) Congenital, which dominates in the younger 
patients, and 3) Rheumatic AS, which is becoming rare in developed countries. 
Patient history and physical examination remain important in the diagnosis of AS. For the 
proper patient management, the evidence of the symptoms characteristic for AS: exertional 
shortness of breath, angina, dizziness, or syncope. Further diagnostic right direction is 
characteristic systolic murmur.  
The disappearance of the second aortic sound is specific to severe AS. 
Aortic valve replacement (AVR) is the only effective treatment for severe aortic AS. It is 
performed either isolated or concomitantly with coronary artery by-pass graft operation, 
which take place in almost 50% of patients with AS. The overall mortality of isolated AVR is 
3-5% in patients below 70 years and 5-15% in elderly. After successful AVR, symptoms and 
quality of live improves significantly. The long term 10 years survival after successful AVR 
is very satisfied and it resulted till 75%. The most important factors that may affect the 
survival are old age, high NYHA functional class, associated aortic regurgitation, 
concomitant coronary aortic by-pass graft and atrial fibrillation.  
2. Echocardiography in aortic stenosis patients  
Echocardiography is the key diagnostic tool, not only to confirm the presence of AS, but also 
to assesses the degree of valve calcification, LV function and wall thickness. Today, 
echocardiography provides prognostic information in patients with AS.  
The severity of AS is provided with a very high sensitivity and specificity by Doppler 
echocardiography. A valve area 1.0 cm2 in a patient with AS is considered severe. The 
indexing of aortic valve area to body surface area is more powerful parameter, and a cut-off 
value of 0.6 cm2/m2 is considered severe AS. However, valve area detected by Doppler 
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echocardiography cannot be the only parameter for clinical decision making for aortic valve 
replacement, and it should be considered in combination with flow rate, pressure gradient 
and ventricular function, as well as functional status of an individual patient.  
In patients with AS and normal left ventricular (LV) ejection fraction (EF) the mean 
pressure gradient of 50 mmHg (Figure 1), was used as a cut-off for the decision making 
for aortic valve replacement. However, in patients with depressed global LV function, 
even in patients with severe AS, Doppler echocardiography may result with low pressure 
gradients (underestimated gradients). In these patients, stress echocardiography using 
low-dose dobutamine may be helpful to distinguish truly severe AS patients from the rare 
cases of pseudosevere AS. In patients with truly severe AS, only small changes in valve 
area, but significant increase in pressure gradients are shown, whereas in pseudosevere 
AS patients are registered significant increase of valve area surface, but only minor 
changes in pressure gradients, before and at peak dose of dobutamine. The dobutamine 
stress-echocardiography is useful also to detect the presence of contractile reserve, which 
has prognostic implications.  
 
 
 
 
 
 
 
 
 
Fig. 1. Continues Doppler velocity of the aortic valve, in a patient with high pressure 
gradient and normal EF, before aortic valve replacement. 
www.intechopen.com
 
Echocardiography in Severe Aortic Stenosis 
 
27 
3. Outcome of patients with aortic stenosis 
Aortic stenosis is a chronic progressive disease. Patients with AS may remain 
asymptomatic for a long period of time, and the duration of the asymptomatic phase 
varies widely among individuals. The most frequent cause of death in symptomatic 
patients is sudden cardiac death. However, sudden cardiac death in asymptomatic 
patients with AS is very rare.  
Older age, presence of atherosclerotic risk factors, valve calcification, peak aortic jet velocity, 
low LV EF and increase of transvalvular pressure gradient with exercise, were shown as 
independent predictors of poor outcome in AS patients.  
The development of symptoms on exercise testing, in physically active patients with AS, 
predicts a very high likelihood of symptom development within 12 months. The occurrence 
of symptoms, in these patientsş is a correlate of poor prognosis. The increased of mortality 
in these patients has been reported within months of symptom onset, which is often not 
promptly reported by patients. 
4. Echocardiographic predictors in patients with severe aortic stenosis and 
poor left ventricular systolic function 
Left ventricular systolic function was shown as one of more important predictors of patients 
with AS. Patients with AS and LV systolic dysfunction have a poor prognosis if valve 
replacement is not performed. LV EF, as the most important conventional parameter for the 
LV global systolic function, was consistently reported as a postoperative prognostic factor in 
patients with severe AS. Patients with severe left ventricular dysfunction have increased 
intra-operative mortality, and there are yet contradictions about their improved outcomes 
after the AVR. Generally, the LV systolic dysfunction is not a contraindication to surgery. It 
was shown that patients who underwent AVR have a 5-year survival rate 60–70%, with a 
high operative mortality in the range of 10–15% for patients with LV systolic dysfunction. 
To predict the postoperative outcome of patients with severe AS and impaired LV function, 
the preoperative dobutamine stress echocardiography is useful technique. The presence of 
good contractile reserve in dobutamine stress echocardiography supports potential benefit 
from AVR and better outcome in these patients.  
AVR decreases the LV afterload, through transvalvular pressure drop (Figure 2), resulting 
in regression of LV hypertrophy.  
LV mass regression predominantly occurs within the first 6 months of surgery. Even there 
are few publications regarding the pre-operative echocardiographic predictors of LV 
functional recovery in AS patients with low EF, it justify the statement to consider these 
patients for the operation, after individual assessment of the patient, considering co 
morbidities and general conditions. 
Recovery of LV function was evident after aortic valve replacement in the majority of 
patients with aortic stenosis and pre-operative LV dysfunction. 
Patients with increased LV end-systolic dimension and/or LV systolic volume index seem 
to have less chance for the LV functional recovery. It seems that these patients loosed 
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contractile reserve, and up to now there is no evidence that they may improve LV systolic 
function after operation, and therefore we should less encourage these patients for the AVR. 
However, there are studies that have shown that even in patients with poor LV systolic 
function, there is still ability for a LV function recovery after AVR, explaining it through the 
mechanism of the markedly reduction of outflow tract resistance.  
Studies have shown that stented and stentless valves have similar effect on the LV mass 
reduction after AVR in all patients that underwent this procedure, despite significant 
differences in indexed effective orifice area and peak flow velocity in favor of the stentless 
valve. However, in patients with AS and markedly reduced ventricular function, there was 
shown more rapid LV mass and function normalization in stentless patients compared to 
similar patients receiving a stented valve. The luck of large randomized studies for these 
prostheses makes even more difficult decision. However, a numerous retrospective studies 
have shown improvement in symptoms and LV EF in about 70% of the survivors after AVR 
in patients with low LV EF.  
 
 
 
 
 
 
 
 
 
 
Fig. 2. Continues Doppler velocity of the aortic valve, in the same patient, two weeks after 
aortic valve replacement. 
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They suggest that despite increased operative mortality, these patients should not be denied 
aortic valve replacement, given the substantial potential clinical benefit from AVR 
replacement. 
In conclusion, in patients with severe aortic stenosis with impaired LV global systolic 
function, assessed by LV EF, AVR has significantly better outcome compared to those 
treated medically. These patients are likely to carry a high risk operation (up to 10%), than 
to have a very poor prognosis for 10 years survival in medical treatment.  
5. Echocardiographic predictors in patients with severe aortic stenosis and 
preserved left ventricular systolic function 
Global LV function, assessed by conventional EF remains normal in most of AS patients. 
However, the long axis systolic function, assessed by M-mode echocardiography and/or 
tissue Doppler imaging (TDI) velocities, decreases even in patients with preserved EF. In AS 
patients with preserved EF, the longitudinal velocity, strain and strain rate are decreased 
and deteriorate further as AS become severe. These changes reflect that the LV myocardial 
dysfunction beginning at the subendocardium in early stages of AS and progress to mid-
wall and to transmural contraction impairment in patients with severe AS. Recent studies 
have shown also that in patients with AS and preserved LV EF, the apical rotation and LV 
twist are increased and untwist is delayed compared to normals, as compensatory 
mechanisms for the increased intracavitary pressure overload and subendocardial 
ischaemia. Also, it was shown that these LV myocardial correlate with the severity of AS. 
However, these compensatory mechanisms are lost after the LV EF deterioration. 
Strong evidence exists showing beneficial effect of AVR, not only in improving patients’ 
symptoms but also in recovering, even partially, overall cardiac function. Improvement of 
LV ventricular function in these patients is interpreted on the basis of regression of 
myocardial hypertrophy, increased myocardial perfusion and hence overall cavity 
performance, at early and mid-term post-operative periods. While EF is the most popular 
measure of pre-operative LV systolic function in such patients, and surgical risk assessment 
it lacks representing subendocardial component of the LV function.  
Severe aortic stenosis causes significant subendocardial dysfunction despite preserved ejection 
fraction. Aortic valve replacement surgery and removal of left ventricular afterload results in 
recovery of intrinsic subendocardial function within a week of surgery, well before mass 
regression and reverse remodeling. Such degree of pre-operative subendocardial disturbances 
may represent early changes that if ignored may substantiate and become irreversible. Thus, 
the presence of such abnormalities in symptomatic patients, even with normal ejection 
fraction, may suggest further evidence for a need for valve replacement in order to maintain 
overall integral ventricular function and to avoid potential clinical complications.  
In patients with severe aortic stenosis and and maintained LV EF, the left ventricular twist 
is increased as compared with normal subjects suggesting a wall motion compensation for 
the reduced long axis motion in the aim to preserve LVEF. These motions alter towards 
normal values within six months of aortic valve replacement (Figure 3). These findings are 
growing evidence that on LV dysfunction and their improvement after AVR, even in 
asymptomatic patients, and may assist in identifying patients needing surgery before LV 
damage becomes irreversible.  
www.intechopen.com
 
Echocardiography – In Specific Diseases 
 
30
 
Fig. 3. Example of LV rotation and twist in control, pre AVR and post AVR. Purple line 
showing peak of apical rotation and green showing peak basal rotation. AVR, aortic valve 
replacement (Reproduced from Lindqvist P et al. Aortic valve replacement normalizes left 
ventricular twist function. Interact CardioVasc Thorac Surg 2011;12:701-706, 
doi:10.1510/icvts.2010.262303, with permission from the European Association for Cardio-
Thoracic Surgery). 
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